| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.543 | 19.408 | 40.591 | 49.081 | 57.933 | 58.687 | 62.886 | 69.710 | 84.655 | 110.730 |
| Total Income - EUR | 5.543 | 21.648 | 40.942 | 49.081 | 57.934 | 60.755 | 62.907 | 69.711 | 84.656 | 123.345 |
| Total Expenses - EUR | 2.262 | 6.643 | 16.059 | 16.222 | 20.499 | 23.115 | 20.412 | 22.903 | 22.182 | 41.555 |
| Gross Profit/Loss - EUR | 3.282 | 15.005 | 24.883 | 32.860 | 37.435 | 37.641 | 42.495 | 46.808 | 62.474 | 81.790 |
| Net Profit/Loss - EUR | 3.115 | 14.538 | 24.477 | 32.369 | 36.887 | 37.148 | 42.296 | 46.231 | 61.811 | 78.529 |
| Employees | 1 | 1 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Eliamedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 253 | 84 | 0 | 22.805 | 18.923 | 15.188 | 11.551 | 8.277 | 4.951 | 42.159 |
| Current Assets | 849 | 14.146 | 25.948 | 29.596 | 19.189 | 36.839 | 33.946 | 40.364 | 58.360 | 41.038 |
| Inventories | 0 | 0 | 0 | 0 | 55 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 47 | 0 | 0 | 320 | 327 | 364 | 1.146 | 31.136 | 27.439 | 10.229 |
| Cash | 802 | 14.146 | 25.948 | 29.277 | 18.807 | 36.475 | 32.800 | 9.228 | 30.921 | 30.810 |
| Shareholders Funds | -1.202 | 13.348 | 24.902 | 39.622 | 36.967 | 38.625 | 43.823 | 46.796 | 62.046 | 80.181 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.305 | 882 | 1.047 | 12.779 | 1.145 | 13.403 | 1.674 | 1.845 | 1.265 | 3.017 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Eliamedica Srl